Interactions between Global Health Initiatives and country health systems: the case of a neglected tropical diseases control program in Mali.
BACKGROUND
Recently, a number of Global Health Initiatives (GHI) have been created to address single disease issues in low-income countries, such as poliomyelitis, trachoma, neonatal tetanus, etc.. Empirical evidence on the effects of such GHIs on local health systems remains scarce. This paper explores positive and negative effects of the Integrated Neglected Tropical Disease (NTD) Control Initiative, consisting in mass preventive chemotherapy for five targeted NTDs, on Mali's health system where it was first implemented in 2007.


RESULTS
Campaign processes and interactions with the health system were assessed through participant observation in two rural districts (8 health centres each). Information was complemented by interviews with key informants, website search and literature review. Preliminary results were validated during feedback sessions with Malian authorities from national, regional and district levels. We present positive and negative effects of the NTD campaign on the health system using the WHO framework of analysis based on six interrelated elements: health service delivery, health workforce, health information system, drug procurement system, financing and governance. At point of delivery, campaign-related workload severely interfered with routine care delivery which was cut down or totally interrupted during the campaign, as nurses were absent from their health centre for campaign-related activities. Only 2 of the 16 health centres, characterized by a qualified, stable and motivated workforce, were able to keep routine services running and to use the campaign as an opportunity for quality improvement. Increased workload was compensated by allowances, which significantly improved staff income, but also contributed to divert attention away from core routine activities. While the campaign increased the availability of NTD drugs at country level, parallel systems for drug supply and evaluation requested extra efforts burdening local health systems. The campaign budget barely financed institutional strengthening. Finally, though the initiative rested at least partially on national structures, pressures to absorb donated drugs and reach short-term coverage results contributed to distract energies away from other priorities, including overall health systems strengthening.


CONCLUSIONS
Our study indicates that positive synergies between disease specific interventions and nontargeted health services are more likely to occur in robust health services and systems. Disease-specific interventions implemented as parallel activities in fragile health services may further weaken their responsiveness to community needs, especially when several GHIs operate simultaneously. Health system strengthening will not result from the sum of selective global interventions but requires a comprehensive approach.
Cavalli
Anna
A
Public Health Department, Institute of Tropical Medicine, Antwerp, Belgium.
Bamba
Sory I
SI
Traore
Mamadou N
MN
Boelaert
Marleen
M
Coulibaly
Youssouf
Y
Polman
Katja
K
Pirard
Marjan
M
Van Dormael
Monique
M
D000977:Antiparasitic Agents / Q000627:therapeutic use*; D018890:Chemoprevention / Q000379:methods*; D003695:Delivery of Health Care / Q000706:statistics & numerical data*; D003906:Developing Countries; D006296:Health Services / Q000706:statistics & numerical data*; D006801:Humans; D008302:Mali / Q000453:epidemiology; D010272:Parasitic Diseases / Q000453:epidemiology* / Q000517:prevention & control*; D015397:Program Evaluation
D000977:Antiparasitic Agents
Science. 2006 Aug 25;313(5790):1077-81
16931751
Health Policy Plan. 2009 Jul;24(4):239-52
19491291
PLoS Med. 2009 Apr 28;6(4):e1000059
19399158
Lancet. 2009 Jun 20;373(9681):2113-24
19541038
J Biosoc Sci. 2008 Mar;40(2):161-81
17761005
PLoS Med. 2005 Nov;2(11):e336
16212468
Lancet. 2004 Sep 4-10;364(9437):900-6
15351199
Hum Resour Health. 2009 Feb 10;7:8
19208253
Health Policy Plan. 2006 Nov;21(6):411-20
16984894
BMJ. 2008 Aug 07;337:a1020
18687725
BMJ. 2001 Jul 21;323(7305):152-4
11463689
Lancet. 2009 May 2;373(9674):1570-5
19410718
N Engl J Med. 2007 Sep 6;357(10):1018-27
17804846
Lancet. 2009 Jul 4;374(9683):10-2
19577680
Trends Parasitol. 2006 Jul;22(7):285-91
16730230
BMJ. 2008 Aug 07;337:a1035
18687726
Int J Health Plann Manage. 2003 Oct-Dec;18 Suppl 1:S5-26
14661938
Trop Med Int Health. 2008 Dec;13(12):1430-2
18983273
Health Policy Plan. 2009 Sep;24(5):335-41
19549795
Int J Health Plann Manage. 2003 Oct-Dec;18 Suppl 1:S27-39
14661939
Lancet. 2009 Jun 20;373(9681):2137-69
19541040
Bull World Health Organ. 2005 Apr;83(4):315-6
15868024
Bull World Health Organ. 2000;78(5):699-709
10859865